These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 836531

  • 1. [Clinical aspects and pathogenesis of multiple sclerosis].
    Neu I, Rodiek S.
    Med Monatsschr; 1977 Jan; 31(1):11-7. PubMed ID: 836531
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis].
    Frick E.
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E, Angstwurm H, Strauss G.
    MMW Munch Med Wochenschr; 1974 Nov 29; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F, Marteau R, de Saxcé H.
    Rev Neurol (Paris); 1987 Nov 29; 143(2):98-107. PubMed ID: 3299618
    [Abstract] [Full Text] [Related]

  • 10. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC, Lance EM, Abbosh J, Munro A, O'Brien J.
    Clin Exp Immunol; 1975 Jul 29; 21(1):23-31. PubMed ID: 1181076
    [Abstract] [Full Text] [Related]

  • 11. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W.
    Postepy Hig Med Dosw; 1978 Jul 29; 32(4):513-22. PubMed ID: 724575
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of multiple sclerosis with antilymphocyte serum: results of a pilot study on 50 patients followed-up over a 4-year period (author's transl)].
    Lhermitte F, Marteau R, De Saxce H.
    Rev Neurol (Paris); 1979 Jun 29; 135(5):389-400. PubMed ID: 538387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Immunosuppressive treatment with azathioprine and antilymphocyte serum in myasthenia].
    Benelli L, Tacconi G, Casacchia M, Paolella P, Agnoli A.
    Riv Neurobiol; 1974 Jun 29; 20(14):87-105. PubMed ID: 4471382
    [No Abstract] [Full Text] [Related]

  • 17. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH.
    Neurology; 1988 Jul 29; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Immunodepressors in ophthalmology].
    Bonnet M.
    Annee Ther Clin Ophtalmol; 1971 Jul 29; 22():117-55. PubMed ID: 4356770
    [No Abstract] [Full Text] [Related]

  • 20. Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis.
    Jones VE, Lance EM, Abbosh J, Graves HE.
    Postgrad Med J; 1976 Jul 29; 52(5 Suppl):136-8. PubMed ID: 1033536
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.